相关实验视频
Updated: Jun 14, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.1K
在慢性疹患者中,用奥马利祖马布调节周围血液T细胞
Cristina López1,2, Nathalie Depreux3, Isabel Bielsa4
1Immunology Division, Laboratori Clinic Metropolitana Nord (LCMN), Germans Trias i Pujol University Hospital and Research Institute (IGTP), Badalona, Spain.
Frontiers in immunology
|September 4, 2024
概括
治疗慢性自发性疹 (CSU) 的奥马利祖马布改变T细胞种群,减少原始细胞和增加记忆子集. 监测这些免疫变化可能有助于预测患者对这种生物疗法的反应.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性自发性疹 (CSU) 是一种普遍的皮肤疾病,常常难以管理.
- 奥马利祖马布是一种抗IgE疗法,用于严重的CSU,特别是与自身免疫联系.
- 识别奥马利祖马布反应的生物标志物可以个性化CSU治疗.
研究的目的:
- 调查奥马利祖马布对CSU患者外围血液淋巴细胞亚群的影响.
- 确定潜在的生物标志物,以预测CSU中的奥马利祖马布治疗疗效.
主要方法:
- 在71名CSU患者 (奥马利祖马布与非免疫调节药物) 和50名健康对照中比较了T细胞亚群.
- 采用多参数流细胞计,对T细胞子集进行详尽的免疫型定型.
- 评估了炎症,亚托皮,自身免疫标志物和临床活性 (疹活动评分7).
主要成果:
- 奥马利祖马布治疗显著减少了原始的CD4 T细胞和增加了中央记忆的CD4 T细胞.
- 奥马利祖马布还减少了原始的CD8 T细胞,并增加了 CD8 T细胞的效应.
- 接受奥马利祖马布治疗的CSU患者的Th1和Th2细胞百分比比较高,而非免疫调节药物患者的Th1和Th2细胞比较高.
结论:
- 在接受奥马利祖马布的CSU患者中,对T细胞亚群的免疫监测是一个可行的策略.
- 这些免疫特征可以作为临床实践中治疗反应的有用生物标志物.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
251
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
251
Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253
T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963

